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Amphiphilic Helices Drive
Signaling
In this issue of Structure, Johnston et al. (2005) report t
the characterization of Gi1:GDP in complex with a r
new GEF peptide KB-752, revealing the atomic detail
of G protein activation and providing a clue to the
energetics of the process.
Dissecting the mechanism underlying signal transduc-
tion is one of the most vital fields in structural and cellu-
lar biology because of its importance for basic science
and its medical relevance as a major source of drug
discovery targets. G protein-coupled receptors (GPCRs)
are the major extracellular signal transducers on the
plasma membrane, and hundreds of GPCRs recognize
diverse physical and chemical signals from the environ-
ment, ranging from photons to large glycoproteins. Ac-
tivated GPCRs induce heterotrimeric G proteins (Gαβγ)
to release GDP from Gα. Gα then binds GTP, amplifying
the signal by initiating successive signaling cascades.
In this capacity, the GPCR functions as a guanine nu-
cleotide exchange factor (GEF). Gα possesses GTPase
activity and thus self-inactivates by hydrolyzing bound
GTP to GDP.
There are a limited number of G protein types, and
the activation mechanism of most G proteins by GPCRs
is thought to be quite similar. Thus the atomic structure
of rhodopsin, the only available structure of a GPCR, is
highly important (Palczewski et al., 2000). However,
while a few structures of rhodopsin are available, all are
substantially of the same inactive form, which leaves
much to be elucidated about the activation mechanism.
In contrast to rhodopsin, there are many structurally
characterized forms of G proteins now known, includ-
ing activated complexes with bound GTP analogs or
GDP AlF4− as well as the G protein βγ dimer and αβγ
trimer (Wall et al., 1995, Lambright et al., 1996).
Small peptides, naturally occurring and laboratory-
generated, have been used to emulate GEF activity. In-
terestingly, these peptides are commonly found as am-
phiphilic helices despite the lack of sequence similarity
among them. Mastoparan, a tetradecapeptide from F
wasp venom, uses a short amphiphilic helix to activate w
Gα proteins as a GEF (Kusunoki et al., 1998). A peptide T
sderived from the C terminus of Gα adopts an amphiphi-
blic helical structure upon rhodopsin binding (Kisselev
1et al., 1998). Furthermore, the farnesylated C-terminal
i
peptide (60–71) of Gγ protein also forms a short amphi- i
philic helix when interacting with activated rhodopsin p
c(Kisselev and Downs, 2003). Additionally, the structure
fof rhodopsin revealed helix 8, an amphiphilic short he-
blix, following transmembrane helix 7 at one of the major
D
sites to interact with G proteins (Hamm, 2001). A crucial t
role for helix 8 in the activation process has since been d
adescribed (Okuno et al., 2003).In this issue of Structure, Johnston et al. (2005) pro-
ide mechanistic and structural characterization of a
eptide selected using phage display, KB-752, with
EF activity. KB-752 was selected for its ability to bind
electively to the GDP-bound form of Gαi1 and it acts
o stimulate release of GDP. Biochemical and structural
esults presented are consistent with a model in whichigure 1. The GPCR Dimer and G Protein Trimer Interaction Model
ith Superimposition of the Gαi1:GDP/KB-752 Structure
he GPCR dimer, based on the inactive rhodopsin structure, is
hown in gold (PBD 1f88), and the inactive G protein trimer with
ound GDP (Gα in cyan, Gβ in aquamarine, and Gγ in teal; PDB
gp2) is modeled. The Gαi1:GDP/KB-752 structure as the activated
ntermediate in red violet (PDB 1y3a) was superimposed on the
nactive Gαi1:GDP (cyan) in the G protein trimer. The bound KB-752
eptide (hotpink) pushes switch II open to widen the GDP binding
left for the release of GDP. Both C-terminal regions suggested to
orm the extended C-terminal α-helical structures (C/Gαi1 and C/Gγ)
ased on NMR experiments (Kisselev et al., 1998; Kisselev and
owns, 2003) were disordered in the crystal structure of the G pro-
ein trimer (Wall et al., 1995). The helix 8 regions of the GPCR (H8)
imer are thought to interact with both the C termini of G protein α
nd γ.
Previews
947the selectivity arises from interaction of the peptide
with the switch II region of the G protein. Consequently,
the crystal structure of the Gαi1:GDP/KB-752 complex
(Figure 1) provides detailed insight into signal transduc-
tion beyond G protein activation by a GPCR.
As shown in Figure 1, the Gαi1:GDP/KB-752 complex
can be modeled to interact with the GPCR dimer as
part of a G protein trimer (Figure 1) (Hamm, 2001; Miy-
ano, 2001). The structural model also fits well with a
proposed mechanism for GDP release, the N-terminal
helix lever model (Bourne, 1997; Johnston et al., 2005),
although it does not specifically exclude other models.
Since KB-752 bound to Gαi1 is the first activating in-
teraction seen in atomic detail, it offers a new perspec-
tive on the energetics of G protein activation. The major
interaction occurs between aromatic residues Trp5 and
Phe8 of KB-752 and the hydrophobic surface of Gαi1
including Trp211 and Phe215. Such a complementary
hydrophobic interaction decreases the water-exposed
hydrophobic surface area, while the entropy decreases
due to the complex formation and conformational re-
straint. These aromatic residue interactions are crucial,
as shown by mutagenesis (Johnston et al., 2005). Fur-
thermore, the enthalpic gain can be supplemented by
the concerted and synergistic hydrogen bonds formed
by the α helix, and the additional interaction of Thr4
with Asp7 (Johnston et al., 2005). Thus, both hydropho-
bic interactions and hydrogen bonding of the short
amphiphilic α helix may supply the free energy for the
activating motive force of G protein signaling. Conse-
quently, interactions via such a short amphiphilic α he-lix may be a common feature in protein-protein acti-
vation.
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